Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II
Lisa M. Oppegard, Andrei V. Ougolkov, Doris N. Luchini, Renee A. Schoon, John R. Goodell, Harneet Kaur, Daniel D. Billadeau, David M. Ferguson, Hiroshi HiasaVolume:
602
Year:
2009
Language:
english
Pages:
7
DOI:
10.1016/j.ejphar.2008.11.044
File:
PDF, 1.67 MB
english, 2009